CIpla finally gets Medpro’s shareholders approval for acquisition

16 May 2013 Evaluate

Shareholders of Cipla Medpro South Africa have finally given nod to Mumbai-based Cipla’s offer to acquire 100% stake in the foreign company. Earlier this year, Cipla offered close to $500 million to buy out South African affiliate Cipla Medpro by sweetening its bid by 17% after earlier talks stalled over price. In November Cipla offered $215 million for 51% of the company.  So, the company would offer 10 South African rand per share, up from its initial bid of 8.55 rand and valuing the company at around 4.5 billion rand ($508 million).

Cipla supplies the bulk of the South African company's drugs through a long-standing agreement; however it has never owned a stake in the Cape Town-based company. This development will give Cipla a direct connect to consumers in South Africa. It also helps the company to integrate its marketing or front-end arm in South Africa with its manufacturing, regulatory and research units.

Cipla Share Price

1517.20 5.10 (0.34%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×